サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：先進がん診断市場：タイプ別、用途別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023年～2030年）
市場調査レポート
商品コード
1388767

先進がん診断市場：タイプ別、用途別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023年～2030年）

Advanced Cancer Diagnostics Market, By Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
先進がん診断市場：タイプ別、用途別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2023年～2030年）
出版日: 2023年11月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

先進がん診断の市場規模は2022年に230億7万米ドルと評価され、2023年～2030年に13.2%のCAGRで拡大すると予測されています。

先端がん診断学は、がんを正確に同定・診断するために最先端の技術や手法を活用します。これらの診断は、患者の転帰を改善し、個々のニーズに合わせて治療を調整し、がん管理を最適化する上で極めて重要です。先進的ながん治療の分野では、免疫療法や標的治療などの革新的な治療法のイントロダクションより、大きな進歩が見られています。さらに、化学療法、放射線療法、外科手術といった従来の治療法も強化されています。例えば、次世代シーケンシング（NGS）やその他のゲノムプロファイリング技術により、がん患者のDNA、RNA、タンパク質プロファイルの解析が可能になり、治療法の決定や予後に役立つ特定の遺伝子変異の同定が容易になっています。

先進がん診断市場 - 市場力学

世界のがん罹患率の上昇が市場成長を促進

がんの発生率は、ライフスタイルの変化、環境要因、高齢化などの多くの要因によって世界的に増加しています。がん患者の増加に伴い、高度な診断技術の必要性が高まっています。世界保健機関（WHO）の報告によると、がんは世界の主要な死因であり、2020年には約1,000万人（死亡者数の約6人に1人）の死因になりました。人口増加と高齢化の予測に基づくと、世界のがんの負担は2040年までに60％以上増加し、2018年の1,810万人に比べ、同年には2,940万人が新たに罹患すると予測されています。加えて、研究開発投資と技術進歩によって市場成長機会が促進されると予想されます。とはいえ、新興国での認知度の低さが市場成長の制約要因となっています。

先進がん診断市場 - セグメンテーション分析：

先進がん診断の世界市場は、タイプ、用途、エンドユーザー、地域に基づいて区分されます。

市場はタイプに基づいて6つに分類される：次世代シーケンサー、ラボオンチップ、細胞解析、リアルタイムPCR（RT_PCR）、マルチプレックスアレイ、高密度マイクロアレイ。次世代シーケンサーが市場を独占次世代シーケンシングの急増は、がんの発生率の上昇、診断における精度の向上への要求、特定のターゲットを持つ治療法の進歩によって推進されています。

市場は用途に基づいて12のカテゴリーに分類される：乳がん、子宮頸がん、大腸がん、前立腺がん、肺がん、皮膚がん、血液がん、肝臓がん、腎臓がん、卵巣がん、膵臓がん、その他。同市場は、乳がん症例の増加、技術の進歩、早期発見の重要性に対する認識の高まりなど、さまざまな要因によって推進されている乳がんセグメントに大きく影響されています。

市場はエンドユーザーによって3つのカテゴリーに分けられる：病院、外来手術センター、診断ラボ、その他です。病院は、がん罹患率の上昇、高度診断ツールに対する需要の増加、早期かつ正確ながん検出と管理の重視の高まりにより、市場を独占しています。

先進がん診断市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米の市場成長は、がん診断に向けた政府機関および民間団体の両方からの資金と投資の急速な流入によって支配されると予測されています。米国やカナダを含む北米の各国政府は、がんの研究や診断を支援するためにさまざまなイニシアチブを打ち出しています。さらに、製薬会社、診断会社、ベンチャーキャピタル企業は、がん診断薬や関連技術に多額の投資を行っています。これらの投資は、革新的な診断ツールや治療法の開発を支援することを目的としています。国際がん研究パートナーシップ（ICR Partners）が実施した2021年の調査によると、研究投資は2018年に85億1,100万米ドルに増加しました。重要なことは、ICRパートナーズが世界のがん研究助成機関のごく一部にすぎないということです。別の調査では、がん研究資金を提供する4,693団体が特定されており、その半数近くが非営利団体に分類され、政府系団体に分類されるのはわずか12％でした。予測期間中、欧州とアジア太平洋が市場の成長を牽引すると予想されます。

先進がん診断市場 - 競合情勢：

先進的がん診断市場は、継続的な技術進歩と進化するヘルスケアニーズに牽引されるダイナミックな性質が特徴です。急速に進化するこの市場で競争力を維持するためには、企業は技術革新、戦略的提携、世界展開を優先しなければならないです。この業界の大手企業は、診断ソリューションの改善に対する需要の高まりに対応するため、先進的な検査や診断を導入しています。血液がん診断薬を専門とするメーカーは、検査プロセスを最適化するために、新しい診断方法の導入やタイプ別の上市に注力しています。さらに、最新の技術やイノベーションを取り入れ、承認プロセスを迅速化するために標準的な方針への準拠を確実にしています。早期発見の分野には、Grail、Guardant、Exact Sciencesのような大企業から、FreenomeやSingleraのような有望な新興企業まで、数多くの主要企業が参入しています。これらの企業は、画期的な発表や業績により、大きな関心と資金を集めています。特筆すべきは、大規模な研究、汎用性の高い機械学習／AIアルゴリズム、汎用のがん検出テスト、数百ドルに及ぶ多額の資金調達などの貢献です。これらの企業はそれぞれ、市場で一線を画す独自の競争優位性を有しています。

目次

第1章 先進がん診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 先進がん診断の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 先進がん診断業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 先進がん診断市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 先進がん診断市場情勢

  • 先進がん診断市場シェア分析（2022年）
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 先進がん診断市場 - タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • 次世代シーケンス
    • ラボオンチップ
    • 細胞解析
    • リアルタイムPCR（RT_PCR）
    • 多重化アレイ
    • 高密度マイクロアレイ

第8章 先進がん診断市場 - 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 胸
    • 子宮頸部
    • 結腸直腸
    • 前立腺
    • 肺
    • 肌
    • 血
    • 肝臓
    • 腎臓
    • 卵巣
    • 膵臓がん
    • その他

第9章 先進がん診断市場 - エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • 外来手術センター
    • 診断研究所
    • その他

第10章 先進がん診断市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 先進がん診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Roche Diagnostics
    • Abbott Laboratories
    • Biocept
    • Beckman Coulter Inc
    • Becton Dickinson and Co.
    • Affymetrix Inc
    • Biotheranostics
    • GE Healthcare
    • Gen-Probe Inc
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Advanced Cancer Diagnostics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Advanced Cancer Diagnostics Market, by Type 2018-2030 (USD Million)
  • TABLE Advanced Cancer Diagnostics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Advanced Cancer Diagnostics Market, by Application 2018-2030 (USD Million)
  • TABLE Advanced Cancer Diagnostics Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Advanced Cancer Diagnostics Market, by End-User 2018-2030 (USD Million)
  • TABLE Advanced Cancer Diagnostics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Advanced Cancer Diagnostics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Advanced Cancer Diagnostics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Europe Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Asia Pacific Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Latin America Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Middle East and Africa Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE Germany Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE India Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE Brazil Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1828

REPORT HIGHLIGHT

Advanced Cancer Diagnostics Market size was valued at USD 23,000.07 Million in 2022, expanding at a CAGR of 13.2% from 2023 to 2030.

Advanced cancer diagnostics utilizes cutting-edge techniques and technologies to accurately identify and diagnose cancer. These diagnostics are crucial in improving patient outcomes, tailoring treatments to individual needs, and optimizing cancer management. The field of advanced cancer treatment has seen significant progress, with the introduction of innovative therapies like immunotherapy and targeted treatments. Additionally, traditional treatment methods such as chemotherapy, radiation, and surgery have also been enhanced. For example, Next-generation sequencing (NGS) and other genomic profiling techniques enable the analysis of a cancer patient's DNA, RNA, and protein profiles, facilitating the identification of specific genetic mutations that inform treatment decisions and prognosis.

Advanced Cancer Diagnostics Market- Market Dynamics

The rising prevalence of cancer cases globally propels the growth of the market

The incidence of cancer has been increasing globally due to a multitude of factors such as changes in lifestyle, environmental factors, and an aging population. With the rise in cancer cases, there is a growing need for advanced diagnostic techniques. The World Health Organization reports that cancer is a leading cause of death worldwide, responsible for almost 10 million deaths in 2020, which is approximately one in six deaths. Based on population growth and aging projections, the global burden of cancer is expected to increase by over 60% by 2040, with a predicted 29.4 million new cases in that year compared to 18.1 million in 2018. Additionally, the market growth opportunity is expected to be propelled by R&D investment and technological advancement. Nevertheless, the lack of awareness in emerging economies poses a limitation to the growth of the market.

Advanced Cancer Diagnostics Market- Key Insights

  • As per the analysis shared by our research analyst, the global Advanced Cancer Diagnostics market is estimated to grow annually at a CAGR of around 13.2% over the forecast period (2023-2030)
  • The Advanced Cancer Diagnostics industry is projected to grow at a significant rate due to the rising prevalence of cancer cases globally.
  • Based on Type segmentation, Next-generation sequencing was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, the breast cancer segment was the leading type in 2022
  • Based on End-User segmentation, Hospitals sector was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Advanced Cancer Diagnostics Market- Segmentation Analysis:

The Global Advanced Cancer Diagnostics Market is segmented on the basis of Type, Application, End-User, and Region.

The market is divided into six categories based on Type: Next-generation sequencing, Lab-on-a-chip, Cellular analysis, Real-time PCR (RT_PCR), Multiplexed arrays, and High-density microarrays. Next-generation sequencing dominates the market. The surge in Next-generation sequencing is propelled by the rising occurrence of cancer, the requirement for enhanced accuracy in diagnostics, and the advancement of therapies with specific targets.

The market is divided into twelve categories based on application: Breast, Cervical, Colorectal, Prostate, Lung, Skin, Blood, Liver, Kidney, Ovarian, Pancreatic cancer, and Others. The market is largely influenced by the breast cancer segment, which is propelled by various factors including rising cases of breast cancer, advancements in technology, and a heightened recognition of the significance of early detection.

The market is divided into three categories based on End-users: Hospitals, Ambulatory surgical centers, Diagnostic Laboratories, and Others. Hospitals dominate the market, due to the rising incidence of cancer, increased demand for advanced diagnostic tools, and the growing emphasis on early and precise cancer detection and management.

Advanced Cancer Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The market growth in North America is projected to be dominated by the rapid influx of funding and investments from both governmental and private entities toward cancer diagnosis. Various initiatives have been launched by governments in North America, including the United States and Canada, to support cancer research and diagnostics. Additionally, pharmaceutical companies, diagnostic companies, and venture capital firms are making significant investments in cancer diagnostics and related technologies. These investments are aimed at supporting the development of innovative diagnostic tools and therapies. According to a 2021 study conducted by the International Cancer Research Partnership (ICR Partners), research investment has increased to USD 8.511 billion in 2018. It is important to note that the ICR Partners represent only a small proportion of global cancer funding bodies. Another study identified 4693 organizations that provide cancer research funding, with nearly half classified as not-for-profit organizations and only 12% classified as governmental organizations. Europe and Asia Pacific are expected to drive the growth of the market in the forecast period.

Advanced Cancer Diagnostics Market- Competitive Landscape:

The advanced cancer diagnostics market is characterized by its dynamic nature, driven by continuous technological advancements and evolving healthcare needs. To maintain a competitive position in this rapidly evolving market, companies must prioritize innovation, strategic partnerships, and global expansion. Leading companies in this industry are introducing advanced tests and diagnostics to meet the growing demand for improved diagnostic solutions. Manufacturers specializing in blood cancer diagnostics are focusing on Type launches and implementing new diagnostic methods to optimize their testing processes. Additionally, they are embracing the latest technologies and innovations, ensuring compliance with standard policies to expedite the approval process. The early detection space is populated by numerous key players, ranging from large corporations like Grail, Guardant, and Exact Sciences to promising startups such as Freenome and Singlera. These companies have garnered significant interest and funding due to their groundbreaking announcements and achievements. Notably, their contributions include large-scale studies, versatile machine learning/AI algorithms, pan-cancer detection tests, and substantial funding ranging from hundreds of dollars. Each of these firms possesses unique competitive advantages that set them apart in the market.

Recent Developments:

On 29 June 2022 - The BenchMark ULTRA PLUS structure, Roche's latest sophisticated tissue staining platform, was launched. The system provides rapid and reliable test findings, allowing doctors to make prompt choices about a patient's treatment path.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET KEY PLAYERS

  • Roche Diagnostics
  • Abbott Laboratories
  • Biocept
  • Beckman Coulter Inc
  • Becton Dickinson and Co.
  • Affymetrix Inc
  • Biotheranostics
  • GE Healthcare
  • Gen-Probe Inc
  • Others

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY TYPE

  • Next generation sequencing
  • Lab-on-a-chip
  • Cellular analysis
  • Real-time PCR (RT_PCR)
  • Multiplexed arrays
  • High density microarrays

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY APPLICATION

  • Breast
  • Cervical
  • Colorectal
  • Prostate
  • Lung
  • Skin
  • Blood
  • Liver
  • Kidney
  • Ovarian
  • Pancreatic cancer
  • Others

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY END-USER

  • Hospitals
  • Ambulatory surgical centers
  • Diagnostic Laboratories
  • Others

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Advanced Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Advanced Cancer Diagnostics Market Snippet by Type
    • 2.1.2. Advanced Cancer Diagnostics Market Snippet by Application
    • 2.1.3. Advanced Cancer Diagnostics Market Snippet by End-User
    • 2.1.4. Advanced Cancer Diagnostics Market Snippet by Country
    • 2.1.5. Advanced Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Advanced Cancer Diagnostics Key Market Trends

  • 3.1. Advanced Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Advanced Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Advanced Cancer Diagnostics Market Opportunities
  • 3.4. Advanced Cancer Diagnostics Market Future Trends

4. Advanced Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Advanced Cancer Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Advanced Cancer Diagnostics Market Landscape

  • 6.1. Advanced Cancer Diagnostics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Advanced Cancer Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Next generation sequencing
    • 7.1.3. Lab-on-a-chip
    • 7.1.4. Cellular analysis
    • 7.1.5. Real-time PCR (RT_PCR)
    • 7.1.6. Multiplexed arrays
    • 7.1.7. High density microarrays

8. Advanced Cancer Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Breast
    • 8.1.3. Cervical
    • 8.1.4. Colorectal
    • 8.1.5. Prostate
    • 8.1.6. Lung
    • 8.1.7. Skin
    • 8.1.8. Blood
    • 8.1.9. Liver
    • 8.1.10. Kidney
    • 8.1.11. Ovarian
    • 8.1.12. Pancreatic cancer
    • 8.1.13. Others

9. Advanced Cancer Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory surgical centers
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Others

10. Advanced Cancer Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Advanced Cancer Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Advanced Cancer Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Advanced Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Advanced Cancer Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Advanced Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Advanced Cancer Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Roche Diagnostics
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Biocept
    • 11.2.4. Beckman Coulter Inc
    • 11.2.5. Becton Dickinson and Co.
    • 11.2.6. Affymetrix Inc
    • 11.2.7. Biotheranostics
    • 11.2.8. GE Healthcare
    • 11.2.9. Gen-Probe Inc
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us